reblozyl
bristol myers squibb pharma eeig - luspatercept - anemia; myelodysplastic syndromes; beta-thalassemia - drugi antianemic priprave - reblozyl is indicated for the treatment of adult patients with transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (mds) with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy (see section 5. reblozyl is indicated in adults for the treatment of anaemia associated with transfusion dependent and non transfusion dependent beta thalassaemia (see section 5.
comtess
orion corporation - entakapon - parkinsonova bolezen - anti-parkinsonska zdravila - entacapone je navedena kot dodatek k standardni pripravki levodopo / benserazide ali levodopo / carbidopa za uporabo pri bolnikih s parkinsonovo boleznijo in konec odmerek motor nihanja, ki ne more ustalilo na teh kombinacij.
fareston
orion corporation - toremifen - neoplazme dojke - endokrini terapija - prva linijska hormonska terapija z metastatskim rakom dojke, ki je odvisna od hormonov pri bolnikih po menopavzi. fareston ni priporočljivo za bolnike z estrogen receptor negativne tumorji,.
antisedan
orion corporation orionintie 1 fi -
domosedan
orion corporation orionintie 1 fi -
domosedan gel
orion corporation orionintie 1 fi -
propomitor
orion corporation orionintie 1 fi -
puri-nethol 50 mg tablete
aspen pharma trading limited - merkaptopurin - tableta - merkaptopurin 50 mg / 1 tableta - merkaptopurin
ketipinor 100 mg filmsko obložene tablete
orion corporation - kvetiapin - žvečljiva tableta - kvetiapin 100 mg / 1 tableta - kvetiapin
ketipinor 200 mg filmsko obložene tablete
orion corporation - kvetiapin - žvečljiva tableta - kvetiapin 200 mg / 1 tableta - kvetiapin